Riehl melanosishttps://en.wikipedia.org/wiki/Riehl_melanosis
Riehl melanosis se yon fòm dèrmatoz kontak, kòmanse ak prurit, eritem, ak pigmantèr ki pwopaje piti piti ki, apre yo fin rive nan yon sèten limit, vin estasyonè. Ekspozisyon solèy apre yo fin itilize kèk pafen oswa krèm ka lakòz maladi a.

☆ Nan rezilta Stiftung Warentest 2022 ki soti nan Almay, satisfaksyon konsomatè yo ak ModelDerm te sèlman yon ti kras pi ba pase ak konsiltasyon telemedsin peye.
      References Riehl Melanosis 32491369 
      NIH
      Riehl melanosis souvan ke yo rekonèt kòm dèrmatoz kontak pigman. Li se yon kalite kondisyon po ki te koze pa alèji, anjeneral deklanche pa parfen ak lòt sibstans yo jwenn nan pwodui kosmetik. Malgre ke yo te klase kòm yon kalite dèrmatit, Riehl melanosis montre chanjman pigmantasyon nan po, ak sèlman ti siy iritasyon. Li pi komen nan moun ki gen ton po pi fonse. Dènye rechèch te eksplore efikasite tretman lazè mid-fluence QSNY 1064-nm pou adrese pigmantasyon pwofon ki asosye ak Riehl melanosis. Yon lòt etid konbine diferan terapi, ki gen ladan low-fluence 1064-nm Q-switched Nd: YAG lazè, krèm idrokinòn, ak asid tranekamik oral, sa ki lakòz amelyorasyon enpòtan pou pifò pasyan yo.
      Riehl melanosis (RM), commonly called pigmented contact dermatitis, is considered an acquired form of allergic contact dermatitis, typically to fragrance and other ingredients of cosmetic products. Although it is considered as a dermatitis, it presents clinically with hyperpigmentation over the face and shows pigment incontinence with minimal eczematous changes on histology. The condition is more commonly seen in dark-skinned people, causing an important psychosocial impact. A recent study showing the higher effectiveness of mid-fluence QSNY 1064-nm laser in targetting the deep pigmentation of RM has also been conducted. Another study used a combination of therapies to include low-fluence, 1064-nm, Q-switched Nd: YAG laser, hydroquinone cream, and oral tranexamic acid, with the majority of patients experiencing significant improvement.
       Research Advances in the Treatment of Riehl’s Melanosis 37168093 
      NIH
      Riehl's melanosis se yon kalite kondisyon po ki te koze pa kontak ak sèten alèrjèn ak ekspoze a limyè solèy la. Li mennen nan pigmantasyon rapid, pwogresif gri-mawon nan po a, ki ka anpil afekte pasyan tou de mantalman ak fizikman. Pandan ke kòz egzak la nan Riehl's melanosis toujou enkoni, rechèch ki egziste deja endike yon lyen solid ak ekspoze alèrjèn. Pou tretman an, yo te eseye tou de medikaman tradisyonèl ak terapi lazè, souvan ansanm ak itilizasyon ajan klowòks aplike sou po a. Terapi lazè, sitou lè l sèvi avèk Q-switched Nd:YAG lazè, te montre rezilta pwomèt pou trete Riehl's melanosis. Konbine diferan apwòch tretman te mennen nan rezilta pozitif.
      Riehl's melanosis (RM) is a contact photodermatitis, with fast progressive gray-brown skin pigmentation as the main manifestation, which can seriously affect the psychology and physiology of patients. Currently, although the etiological factors of Riehl's melanosis is still be unknown, the existing literature proves clearly the cause of it is related to the contacting with suspected allergens. For decades, there has been no standard method for the treatment of RM, but with both conventional drug therapy and laser therapy having been attempted. Topical application of bleaching agents is mainly used as an auxiliary treatment modality. The laser treatment modality remains a hot spot, among which Q-switched Nd:YAG laser is well received for RM. Positive outcomes have been achieved by the combined treatment modalities attempted in recent years also achieve positive outcomes.